Literature DB >> 17002545

Evaluation and genotyping of multidrug-resistant cases of tuberculosis in southern Brazil.

Andréia Rosane de Moura Valim1, Lia Gonçalves Possuelo, Patrícia Izquierdo Cafrune, Michele Borges, Marta Osório Ribeiro, Maria Lúcia Rosa Rossetti, Arnaldo Zaha.   

Abstract

Sixty isolates of Mycobacterium tuberculosis identified as multidrug-resistant (MDR) at a reference laboratory in Rio Grande do Sul State during the years 1999 and 2000 were analyzed using the IS6110-restriction fragment length polymorphism (RFLP) technique. We also genotyped 202 susceptible strains to compare the genotyping results, as well as the clinical and demographic data. Spacer oligotyping (spoligotyping) analysis was performed for isolates presenting low IS6110 copy number. Patients with identical DNA pattern strains were considered clustered. From 262 isolates, 94 (36%) belonged to 20 distinct RFLP clusters, and after spoligotyping analysis, 89 of the isolates (34%) remained in cluster. MDR isolates did not differ statistically in clustering proportion from susceptible strains. A significant association between the occurrence of MDR and previous tuberculosis (TB) treatment was observed (p < 0.001), as well as failure on TB treatment (p < 0.001). Human immunodeficiency virus (HIV)-positive patients were associated with susceptible tuberculosis (p = 0.024). We also identified that unmarried patients were more likely to develop TB due to recent transmission than married patients (p < 0.005). The introduction of directly observed therapy short-course (DOTS) strategy will be important in decreasing default and failure rates and avoiding the development of new MDR strains.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17002545     DOI: 10.1089/mdr.2006.12.186

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  6 in total

1.  Factors associated with primary transmission of multidrug-resistant tuberculosis compared with healthy controls in Henan Province, China.

Authors:  Wei-Bin Li; Yan-Qiu Zhang; Jin Xing; Zhen-Ya Ma; Ya-Hong Qu; Xin-Xu Li
Journal:  Infect Dis Poverty       Date:  2015-03-24       Impact factor: 4.520

2.  Recent transmission of drug-resistant Mycobacterium tuberculosis in a prison population in southern Brazil.

Authors:  Ana Julia Reis; Simone Maria Martini de David; Luciana de Souza Nunes; Andreia Rosane de Moura Valim; Lia Gonçalves Possuelo
Journal:  J Bras Pneumol       Date:  2016 Jul-Aug       Impact factor: 2.624

Review 3.  Molecular epidemiology of Mycobacterium tuberculosis in Brazil before the whole genome sequencing era: a literature review.

Authors:  Emilyn Costa Conceição; Richard Steiner Salvato; Karen Machado Gomes; Arthur Emil Dos Santos Guimarães; Marília Lima da Conceição; Ricardo José de Paula Souza E Guimarães; Abhinav Sharma; Ismari Perini Furlaneto; Regina Bones Barcellos; Valdes Roberto Bollela; Lívia Maria Pala Anselmo; Maria Carolina Sisco; Cristina Viana Niero; Lucilaine Ferrazoli; Guislaine Refrégier; Maria Cristina da Silva Lourenço; Harrison Magdinier Gomes; Artemir Coelho de Brito; Marcos Catanho; Rafael Silva Duarte; Philip Noel Suffys; Karla Valéria Batista Lima
Journal:  Mem Inst Oswaldo Cruz       Date:  2021-03-15       Impact factor: 2.743

4.  Mycobacterium tuberculosis Complex Genotype Diversity and Drug Resistance Profiles in a Pediatric Population in Mexico.

Authors:  Mercedes Macías Parra; Jesús Kumate Rodríguez; José Luís Arredondo García; Yolanda López-Vidal; Mauricio Castañón-Arreola; Susana Balandrano; Nalin Rastogi; Pedro Gutiérrez Castrellón
Journal:  Tuberc Res Treat       Date:  2011-08-23

5.  Incidence and transmission patterns of tuberculosis among indigenous populations in Brazil.

Authors:  Eunice Atsuko Cunha; Lucilaine Ferrazoli; Lee W Riley; Paulo Cesar Basta; Michael Robert Honer; Rosalia Maia; Izaias Pereira da Costa
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-11-04       Impact factor: 2.743

6.  Determinants of multidrug-resistant tuberculosis in Henan province in China: a case control study.

Authors:  Chunxiao Zhang; Yongliang Wang; Guangcan Shi; Wei Han; Huayang Zhao; Huiqiang Zhang; Xiue Xi
Journal:  BMC Public Health       Date:  2016-01-16       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.